Table 3.
Comparison of COVID-19-related and unrelated strokes in terms of acute treatment approaches
|
COVID-related
acute stroke |
COVID-unrelated
acute stroke |
Total | ||||
|---|---|---|---|---|---|---|
| n | % | n | % | n | % | |
| iv-tPA | 3 | 13.0 | 18 | 11.2 | 21 | 11.4 |
| MT | 0 | 0.0 | 11 | 6.8 | 11 | 6.0 |
| iv-tPA+MT | 1 | 4,3 | 7 | 4.3 | 8 | 4.3 |
| None | 19 | 82.6 | 125 | 77.6 | 144 | 78.2 |
| Total | 23 | 100.0 | 161 | 100.0 | 184 | 100.0 |
iv-tPA: Intravenous tissue plasminogen activator; MT: Mechanical thrombectomy.